Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program.

about

Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program.

Item

http://www.wikidata.org/entity/Q52592715

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Hepatitis C Treatment Outcomes ...... at a Syringe Service Program.

@en

Hepatitis C Treatment Outcomes ...... at a Syringe Service Program.

@nl

type

Item

label

Hepatitis C Treatment Outcomes ...... at a Syringe Service Program.

@en

Hepatitis C Treatment Outcomes ...... at a Syringe Service Program.

@nl

prefLabel

Hepatitis C Treatment Outcomes ...... at a Syringe Service Program.

@en

Hepatitis C Treatment Outcomes ...... at a Syringe Service Program.

@nl

P1476

Hepatitis C Treatment Outcomes ...... at a Syringe Service Program.

@en

P2093

Benjamin J Eckhardt

http://www.w3.org/2001/XMLSchema#string

Brian R Edlin

http://www.w3.org/2001/XMLSchema#string

Emily Winkelstein

http://www.w3.org/2001/XMLSchema#string

Kristen Marks

http://www.w3.org/2001/XMLSchema#string

Matthew Scherer

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients

Successful treatment of chronic hepatitis C with triple therapy in an opioid agonist treatment program.

Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy.

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

Epidemiology and natural history of HCV infection.

Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.

High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic.

Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting.

Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.

Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.

P304

ofy048

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/OFID/OFY048

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29644246

http://www.w3.org/2001/XMLSchema#string

P932

5887278

http://www.w3.org/2001/XMLSchema#string